search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
CHAPTER 6 daily schedule.7 Energy needs should be determined with the patient and


based on a goal weight for weight maintenance, weight gain, or weight loss. An administration schedule should be created, and blood glucose and serum electrolyte levels need to be stable before discharge. Patient intake and output data should be evaluated before hospital discharge to ensure that the HPN formula provides sufficient fluid for adequate urine production and that it accounts for all GI losses (eg, diarrhea, stoma or fistula effluent, emesis, gastrostomy tube output, or drains). The HPN formula should not provide excess fluid because this could lead to fluid overload, especially for patients with underlying comorbidities (eg, car- diac failure). Ensuring that the patient is receiving a stable PN formula before discharge should allow for weekly monitoring of laboratory values; more frequent monitoring is often not realistic in the home setting.7 The HPN formula should be similar to the hospital PN formula and con-


sist of macronutrients, vitamins, minerals, and electrolytes. HPN formulas may be made as a 2-in-1 (dextrose and protein) or 3-in-1 (dextrose, protein, and lipid) formula. Patients receiving 2-in-1 formulas where PN is the sole source of nutrition require lipids, which are infused separately, to be given at least once per week to meet essential fatty acid requirements. Patients who receive and absorb fat from oral or enteral nutrition may not need to receive IV lipids. Refer to Chapter 3 for more information on PN formulas. Some medications normally added to PN formulas prepared daily by


a hospital pharmacy cannot be premixed in HPN formulas because they are not stable for extended periods of time. Patients must be taught to inject these medications, which may include multivitamins, histamine 2-receptor antagonists, insulin, and octreotide, into their HPN formulas daily.18


Infusion Schedule


Patients receiving HPN typically have their HPN formula cycled during part of the day, which provides the following benefits:


ƒ Cycling allows the patient freedom from the pump and other PN equipment for a portion of the day, promoting a more normal life- style.


ƒ It allows time to administer other IV medications, such as anti- biotics or chemotherapy.


ƒ A cycled infusion may prevent parenteral nutrition–associated liver disease (PNALD) because the liver is not continuously


metabolizing the nutrients from the PN. This allows mobilization of stored glycogen and decreases the incidence of fatty liver.19,20


94


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149